ahlam1399
01-20-2017, 08:11 PM
BRIEF-OncoMed initiates enrollment of phase 1B clinical trial of Brontictuzumab
* OncoMed initiates enrollment of phase 1B clinical trial of Brontictuzumab for the treatment of metastatic colorectal cancer patients Source text for Eikon: Further company coverage: http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=4OyjuJ0VAnk:Dl7aY_t5pWM:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=4OyjuJ0VAnk:Dl7aY_t5pWM:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=4OyjuJ0VAnk:Dl7aY_t5pWM:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=4OyjuJ0VAnk:Dl7aY_t5pWM:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=4OyjuJ0VAnk:Dl7aY_t5pWM:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/4OyjuJ0VAnk
* OncoMed initiates enrollment of phase 1B clinical trial of Brontictuzumab for the treatment of metastatic colorectal cancer patients Source text for Eikon: Further company coverage: http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=4OyjuJ0VAnk:Dl7aY_t5pWM:yI l2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=4OyjuJ0VAnk:Dl7aY_t5pWM:V_ sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=4OyjuJ0VAnk:Dl7aY_t5pWM:V_ sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/governmentfilingsNews?i=4OyjuJ0VAnk:Dl7aY_t5pWM:F7 zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/governmentfilingsNews?a=4OyjuJ0VAnk:Dl7aY_t5pWM:F7 zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/governmentfilingsNews/~4/4OyjuJ0VAnk